Physicochemical Properties
Molecular Formula | C8H7NAO4 |
Molecular Weight | 190.13 |
Exact Mass | 190.024 |
CAS # | 4418-26-2 |
PubChem CID | 23675081 |
Appearance | Off-white to yellow solid powder |
Boiling Point | 332.6ºC at 760 mmHg |
Melting Point | ~295 °C (dec.) |
Flash Point | 150.6ºC |
LogP | 1.294 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Heavy Atom Count | 13 |
Complexity | 314 |
Defined Atom Stereocenter Count | 0 |
SMILES | C([C-]1C(OC(C)=CC1=O)=O)(=O)C.[Na+] |
InChi Key | DSOWAKKSGYUMTF-GZOLSCHFSA-M |
InChi Code | InChI=1S/C8H8O4.Na/c1-4-3-6(10)7(5(2)9)8(11)12-4;/h3,9H,1-2H3;/q;+1/p-1/b7-5+; |
Chemical Name | sodium;(1E)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
Toxicity/Toxicokinetics |
Interactions Toxicological potentiation of 2 food additives was investigated in male and female Wistar rats given sodium dehydroacetate (DHA-Na) and dibutyl hydroxy toluene (BHT) in the diet for 6 months. No marked potentiation of toxicity was observed with the combination of DHA-Na and BHT regardless of the dosage. |
References | [1]. Baldwin AG, et al. Synthesis and antibacterial activities of enamine derivatives of dehydroacetic acid. Med Chem Res. 2018;27(3):884-889. |
Additional Infomation |
Sodium dehydroacetate is a white powder. Used as a fungicide, plasticizer, toothpaste, preservative in food. See also: Sodium Dehydroacetate (annotation moved to). |
Solubility Data
Solubility (In Vitro) | DMSO : 125 mg/mL (657.44 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (10.94 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (10.94 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (10.94 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 5.2596 mL | 26.2978 mL | 52.5956 mL | |
5 mM | 1.0519 mL | 5.2596 mL | 10.5191 mL | |
10 mM | 0.5260 mL | 2.6298 mL | 5.2596 mL |